American Express Company · AXP · FY2025 Q2 · Calendar Q3 2025
American Express: Premium-card momentum meets execution risks
The current and prior analyses support a constructive but conditional view: premium-card growth, fee momentum, product refreshes, and international expansion support the growth case, while competition, travel sensitivity, expense execution, and SMB losses remain material tests.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about AXP FY2025 Q2
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Relative to the prior analysis, management added greater emphasis on the upcoming U.S. Platinum refresh, airport-lounge expansion through Sidecar concepts, international merchant acquisition, and the Coinbase stablecoin partnership. The broader product-refresh and technology-investment strategy continued.
Guidance delta
Maintained; management reaffirmed full-year 2025 guidance of 8–10% revenue growth and $15–$15.50 EPS.
Key takeaways
- Management described record Q2 revenue and EPS, with premium cards supporting double-digit card-fee growth and strong credit quality.
- The company reaffirmed full-year 2025 guidance and plans a U.S. Platinum refresh in the fall.
- New emphasis includes international merchant expansion, airport-lounge capacity, and a Coinbase stablecoin partnership.
Management priorities
- Execute the U.S. Platinum card refresh and continue global premium-product refreshes.
- Expand airport-lounge capacity, including Sidecar micro-lounges.
- Accelerate international merchant acquisition and coverage.
- Deepen the Coinbase stablecoin partnership and explore further blockchain use cases.
- Continue investment in technology, risk management, and product innovation.
Follow AXP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Nov 2, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 27, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 26, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 26, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 12, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 9, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 6, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 1, 2026 |
| Truist Securities | Buy | Buy | Maintain | Sep 23, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 12, 2026 |
| BTIG | Sell | Sell | Maintain | Jul 27, 2026 |
| HSBC | Hold | Hold | Maintain | Jul 13, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 28, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 9, 2026 |
| Freedom Capital Markets | Hold | Sell | Upgrade | Oct 24, 2025 |
| Freedom Broker | Hold | Sell | Upgrade | Oct 24, 2025 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 1, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 21, 2025 |
| Redburn Atlantic | Neutral | Sell | Upgrade | Apr 23, 2025 |
| Monness, Crespi, Hardt | Buy | Buy | Maintain | Apr 8, 2025 |
| Baird | Neutral | Underperform | Upgrade | Mar 14, 2025 |
| Compass Point | Neutral | Neutral | Maintain | Jan 27, 2025 |
| Jefferies | Hold | Hold | Maintain | Jul 9, 2024 |
| BMO Capital | Underperform | Underperform | Maintain | Apr 22, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 5, 2024 |
| Stephens & Co. | Equal Weight | Underweight | Upgrade | Jan 2, 2024 |
| DZ Bank | Hold | Buy | Downgrade | Jul 25, 2023 |
| Argus Research | Buy | Buy | Maintain | Jan 31, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Jan 30, 2023 |
| Redburn Partners | Neutral | Neutral | Maintain | Nov 29, 2022 |
| Atlantic Equities | Neutral | Neutral | Maintain | Oct 12, 2022 |
| CFRA | Buy | Buy | Maintain | Jul 22, 2022 |
| Edward Jones | Buy | Hold | Upgrade | Jun 6, 2022 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | May 12, 2022 |
| Daiwa Capital | Buy | Hold | Upgrade | Feb 10, 2022 |
| Seaport Global | Neutral | Neutral | Maintain | Aug 30, 2021 |
| Susquehanna | Neutral | Neutral | Maintain | Jan 12, 2021 |
| Nomura | Buy | Buy | Maintain | Mar 20, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Dec 19, 2018 |
| Buckingham Research | Neutral | Buy | Downgrade | Nov 29, 2018 |
| Buckingham | Neutral | Buy | Downgrade | Nov 29, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Guggenheim | Buy | Neutral | Upgrade | Apr 25, 2017 |
| Tigress Financial | Neutral | Neutral | Maintain | Mar 24, 2017 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Jan 30, 2017 |
| Macquarie | Underperform | Underperform | Maintain | Apr 21, 2016 |
| DA Davidson | Neutral | Neutral | Maintain | Jan 13, 2016 |
| JMP Securities | Perform | Market Perform | Maintain | Dec 22, 2015 |
| Bernstein | Outperform | Outperform | Maintain | May 6, 2015 |
| Sandler O'Neil | Buy | Hold | Upgrade | Oct 20, 2014 |
| Pacific Crest | Perform | Sector Perform | Maintain | Jun 16, 2014 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Feb 5, 2014 |
| Janney Capital | Buy | Neutral | Upgrade | Feb 5, 2014 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Dec 19, 2013 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Dec 19, 2012 |
| PiperJaffray | Neutral | Neutral | Maintain | Apr 19, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $301.7. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $330 | $315.05 | +9.4% | Oct 27, 2026 |
| Citigroup | Benjamin Gerlinger | $335 | $312.91 | +11.0% | Oct 27, 2026 |
| J.P. Morgan | Analyst unavailable | $365 | $315.05 | +21.0% | Oct 26, 2026 |
| Barclays | Analyst unavailable | $340 | $313.03 | +12.7% | Oct 26, 2026 |
| Bank of America Securities | Mihir Bhatia | $369 | $313.22 | +22.3% | Oct 26, 2026 |
| Jefferies | John Hecht | $330 | $314.64 | +9.4% | Oct 23, 2026 |
| Morgan Stanley | Jeffrey Adelson | $380 | $308.17 | +26.0% | Oct 12, 2026 |
| RBC Capital | Analyst unavailable | $400 | $307.02 | +32.6% | Oct 9, 2026 |
| BMO Capital | Andrew Bauch | $380 | $308.1 | +26.0% | Oct 8, 2026 |
| UBS | Analyst unavailable | $345 | $302.78 | +14.4% | Oct 5, 2026 |
| Barclays | Analyst unavailable | $342 | $302.78 | +13.4% | Oct 5, 2026 |
| Evercore ISI | Analyst unavailable | $320 | $304.1 | +6.1% | Oct 1, 2026 |
| UBS | Erika Najarian | $384 | $336.25 | +27.3% | Aug 3, 2026 |
| Morgan Stanley | Analyst unavailable | $382 | $332.24 | +26.6% | Jul 27, 2026 |
| Evercore ISI | Analyst unavailable | $370 | $331.4 | +22.6% | Jul 27, 2026 |
| BTIG | Analyst unavailable | $315 | $326.17 | +4.4% | Jul 27, 2026 |
| HSBC | Analyst unavailable | $329 | $350.58 | +9.0% | Jul 13, 2026 |
| UBS | Analyst unavailable | $386 | $355.4 | +27.9% | Jul 7, 2026 |
| Barclays | Analyst unavailable | $364 | $356.03 | +20.6% | Jul 7, 2026 |
| Evercore ISI | Analyst unavailable | $380 | $354.51 | +26.0% | Jul 6, 2026 |
| BTIG | Analyst unavailable | $324 | $340.88 | +7.4% | Jun 30, 2026 |
| Piper Sandler | Analyst unavailable | $396 | $340.88 | +31.3% | Jun 29, 2026 |
| Loop Capital Markets | Analyst unavailable | $389 | $309.7 | +28.9% | May 21, 2026 |
| Evercore ISI | John Pancari | $345 | $316.15 | +14.4% | Apr 29, 2026 |
| Goldman Sachs | Analyst unavailable | $400 | $318.88 | +32.6% | Apr 28, 2026 |
| Barclays | Analyst unavailable | $322 | $318.38 | +6.7% | Apr 24, 2026 |
| Morgan Stanley | Jeffrey Adelson | $385 | $326.96 | +27.6% | Apr 16, 2026 |
| RBC Capital | Analyst unavailable | $415 | $313.84 | +37.6% | Apr 10, 2026 |
| Wells Fargo | Analyst unavailable | $415 | $317.77 | +37.6% | Apr 9, 2026 |
| Evercore ISI | John Pancari | $393 | $367.72 | +30.3% | Feb 10, 2026 |
| UBS | Erika Najarian | $395 | $355.23 | +30.9% | Feb 4, 2026 |
| Truist Financial | Analyst unavailable | $400 | $352.46 | +32.6% | Feb 2, 2026 |
| Morgan Stanley | Jeffrey Adelson | $395 | $356.52 | +30.9% | Jan 20, 2026 |
| RBC Capital | Analyst unavailable | $425 | $359.34 | +40.9% | Jan 12, 2026 |
| Credit Suisse | Analyst unavailable | $328 | $375.61 | +8.7% | Jan 12, 2026 |
| UBS | Analyst unavailable | $385 | $375.61 | +27.6% | Jan 12, 2026 |
| BTIG | Vincent Caintic | $328 | $375.61 | +8.7% | Jan 12, 2026 |
| Evercore ISI | John Pancari | $400 | $380.42 | +32.6% | Jan 6, 2026 |
| Goldman Sachs | Analyst unavailable | $420 | $378.23 | +39.2% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $367 | $379.8 | +21.6% | Jan 6, 2026 |
| Truist Financial | Analyst unavailable | $420 | $377.42 | +39.2% | Dec 22, 2025 |
| Wells Fargo | Analyst unavailable | $425 | $380.75 | +40.9% | Dec 17, 2025 |
| Morgan Stanley | Jeffrey Adelson | $370 | $381.96 | +22.6% | Dec 16, 2025 |
| Compass Point | Dominick Gabriele | $324 | $343.23 | +7.4% | Oct 20, 2025 |
| Truist Financial | Brian Foran | $395 | $343.98 | +30.9% | Oct 20, 2025 |
| BTIG | Analyst unavailable | $307 | $346.62 | +1.8% | Oct 20, 2025 |
| Barclays | Analyst unavailable | $355 | $346.62 | +17.7% | Oct 20, 2025 |
| Wells Fargo | Analyst unavailable | $400 | $346.62 | +32.6% | Oct 20, 2025 |
| HSBC | Saul Martinez | $295 | $324.44 | -2.2% | Oct 10, 2025 |
| UBS | Analyst unavailable | $340 | $327.16 | +12.7% | Oct 7, 2025 |
| Barclays | Analyst unavailable | $336 | $330.24 | +11.4% | Oct 6, 2025 |
| Evercore ISI | Analyst unavailable | $365 | $342.31 | +21.0% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $362 | $341.68 | +20.0% | Sep 29, 2025 |
| Truist Financial | Brian Foran | $375 | $327.26 | +24.3% | Sep 15, 2025 |
| Wells Fargo | Analyst unavailable | $375 | $326.22 | +24.3% | Sep 5, 2025 |
| BTIG | Vincent Caintic | $277 | $318.99 | -8.2% | Jul 14, 2025 |
| Wells Fargo | Analyst unavailable | $327 | $325.61 | +8.4% | Jul 2, 2025 |
| Truist Financial | Analyst unavailable | $315 | $242.51 | +4.4% | Apr 21, 2025 |
| Compass Point | David Rochester | $325 | $302.11 | +7.7% | Dec 19, 2024 |
| Morgan Stanley | Jeff Adelson | $252 | $275.28 | -16.5% | Oct 21, 2024 |
| Monness | Gus Gala | $300 | $276.16 | -0.6% | Oct 14, 2024 |
| HSBC | Saul Martinez | $270 | $273.79 | -10.5% | Oct 8, 2024 |
| BTIG | Vincent Caintic | $230 | $273.79 | -23.8% | Oct 8, 2024 |
| Bank of America Securities | Mihir Bhatia | $280 | $270.38 | -7.2% | Sep 23, 2024 |
| Bank of America Securities | Mihir Bhatia | $263 | $253.08 | -12.8% | Aug 21, 2024 |
| Monness | Gus Gala | $265 | $242.38 | -12.2% | Jul 22, 2024 |
| RBC Capital | Jon Arfstrom | $267 | $242.38 | -11.5% | Jul 22, 2024 |
| RBC Capital | Jon Arfstrom | $263 | $249.2 | -12.8% | Jul 19, 2024 |
| Compass Point | David Rochester | $260 | $244 | -13.8% | Jul 15, 2024 |
| Wells Fargo | Donald Fandetti | $285 | $234.51 | -5.5% | Jul 9, 2024 |
| Wells Fargo | Donald Fandetti | $275 | $224.04 | -8.8% | Jun 13, 2024 |
| Citigroup | Keith Horowitz | $250 | $224.53 | -17.1% | Jun 11, 2024 |
| BMO Capital | James Fotheringham | $175 | $233 | -42.0% | Apr 22, 2024 |
| Monness | Gus Gala | $250 | $228.62 | -17.1% | Apr 19, 2024 |
| Argus Research | Stephen Biggar | $246 | $230.32 | -18.5% | Apr 19, 2024 |
| Barclays | Terry Ma | $221 | $224.11 | -26.7% | Apr 9, 2024 |
| Monness | Gus Gala | $245 | $219.59 | -18.8% | Apr 5, 2024 |
| BMO Capital | James Fotheringham | $159 | $218.46 | -47.3% | Mar 15, 2024 |
| RBC Capital | Jon Arfstrom | $226 | $200.86 | -25.1% | Jan 29, 2024 |
| RBC Capital | Jon Arfstrom | $185 | $188.07 | -38.7% | Jan 26, 2024 |
| Loop Capital Markets | James Fotheringham | $157 | $184.97 | -48.0% | Jan 10, 2024 |
| Citigroup | Keith Horowitz | $143 | $149.62 | -52.6% | Oct 20, 2023 |
| BMO Capital | James Fotheringham | $194 | $167.79 | -35.7% | Jul 24, 2023 |
| Oppenheimer | Dominick Gabriele | $180 | $174.48 | -40.3% | Jun 30, 2023 |
| Morgan Stanley | Betsy Graseck | $186 | $178.72 | -38.3% | Feb 8, 2023 |
| Wells Fargo | Analyst unavailable | $180 | $146.79 | -40.3% | Dec 15, 2022 |
| Piper Sandler | Analyst unavailable | $159 | $157.31 | -47.3% | Dec 13, 2022 |
| Morgan Stanley | Analyst unavailable | $148 | $155.31 | -50.9% | Dec 1, 2022 |
| New Street | Mihir Bhatia | $172 | $132.83 | -43.0% | Oct 21, 2022 |
| Atlantic Equities | Kunaal Malde | $165 | $141.01 | -45.3% | Oct 13, 2022 |
| BMO Capital | Analyst unavailable | $169 | $152.36 | -44.0% | Jul 26, 2022 |
| RBC Capital | Analyst unavailable | $180 | $154.11 | -40.3% | Jul 25, 2022 |
| Stephens | Analyst unavailable | $157 | $153.01 | -48.0% | Jul 25, 2022 |
| Morgan Stanley | Analyst unavailable | $155 | $153.01 | -48.6% | Jul 25, 2022 |
| Barclays | Analyst unavailable | $160 | $153.01 | -47.0% | Jul 25, 2022 |
| Barclays | Mark DeVries | $157 | $142.48 | -48.0% | Jul 17, 2022 |
| Wells Fargo | Donald Fandetti | $190 | $136.48 | -37.0% | Jul 15, 2022 |
| Morgan Stanley | Betsy Graseck | $143 | $140.58 | -52.6% | Jul 12, 2022 |
| Piper Sandler | Analyst unavailable | $163 | $139.65 | -46.0% | Jul 6, 2022 |
| Wolfe Research | Bill Carcache | $146 | $158.75 | -51.6% | May 13, 2022 |
| Citigroup | Arren Cyganovich | $190 | $169.63 | -37.0% | May 2, 2022 |
| RBC Capital | Jon Arfstrom | $200 | $181.98 | -33.7% | Apr 28, 2022 |
| Oppenheimer | Dominick Gabriele | $225 | $185.4 | -25.4% | Apr 5, 2022 |
| Morgan Stanley | Betsy Graseck | $218 | $187.17 | -27.7% | Apr 2, 2022 |
| Wolfe Research | Bill Carcache | $226 | $190.28 | -25.1% | Mar 26, 2022 |
| Wells Fargo | Donald Fandetti | $215 | $194.88 | -28.7% | Feb 21, 2022 |
| Daiwa | Kazuya Nishimura | $215 | $191.81 | -28.7% | Feb 12, 2022 |
| Citigroup | Jill Shea | $187 | $171.41 | -38.0% | Jan 27, 2022 |
| Stephens | Vincent Caintic | $197 | $174.82 | -34.7% | Jan 26, 2022 |
| Barclays | Mark Devries | $190 | $174.82 | -37.0% | Jan 26, 2022 |
| Credit Suisse | Moshe Orenbuch | $170 | $174.82 | -43.7% | Jan 26, 2022 |
| BMO Capital | James Fotheringham | $155 | $174.82 | -48.6% | Jan 26, 2022 |
| J.P. Morgan | Richard Shane | $200 | $174.82 | -33.7% | Jan 26, 2022 |
| Deutsche Bank | Meng Jiao | $210 | $172.62 | -30.4% | Jan 25, 2022 |
| Barclays | Mark DeVries | $182 | $168.4 | -39.7% | Jan 16, 2022 |
| Jefferies | John Hecht | $180 | $170.84 | -40.3% | Jan 5, 2022 |
| Piper Sandler | Christopher Donat | $202 | $181.34 | -33.0% | Oct 25, 2021 |
| DZ BANK AG | Werner Eisenmann | $185 | $171.59 | -38.7% | Jul 27, 2021 |
| Argus Research | Stephen Biggar | $200 | $171.26 | -33.7% | Jul 26, 2021 |
| Goldman Sachs | Ryan Nash | $225 | $168.24 | -25.4% | Jul 6, 2021 |
| MoffettNathanson | Lisa Elis | $170 | $148.78 | -43.7% | Apr 26, 2021 |
Track every rating change on AXP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationOperating globally, American Express Company and its affiliated entities deliver a comprehensive suite of charge and credit payment card solutions, alongside a variety of travel-related offerings. Its business structure is organized into three primary divisions: the Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Among its core offerings are diverse payment and financing instruments, robust network infrastructure services, tools for managing accounts payable expenses, and comprehensive travel and lifestyle support.…
Historical context
All AXP earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FUTU Futu Holdings Limited | FY2026 Q3 · Calendar Q4 2026 | -7.8% | +4.8% | Futu’s Q3 shows strong client inflows, but guidance remains unspecified |
| XP XP Inc. | FY2026 Q3 · Calendar Q4 2026 | -3.0% | -2.5% | XP’s Q3 growth centers on retail, offshore expansion and capital returns |
| BN Brookfield Corporation | FY2026 Q3 · Calendar Q4 2026 | -6.1% | -1.0% | Brookfield’s Q3 earnings rose as fundraising and Wealth Solutions gained traction |
| NU Nu Holdings Ltd. | FY2026 Q3 · Calendar Q4 2026 | -2.8% | -4.0% | Nu reports record Q3 revenue as credit and international expansion grow |
Latest beats and misses
Who reports nextBeat on EPS
- BJFY2026 Q3 · November 20, 2026+37.3% EPS-5.4% move
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
Missed on EPS
- FROFY2026 Q3 · November 20, 2026-11.5% EPS+1.0% move
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
Get the AXP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-10-06T07:30:42.275771+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-06T07:30:42.272987+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-06. For educational purposes only; not investment advice.